Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 911 of 1,261
  1. US 8244344

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  2. US 8242156

    Linked dibenzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  3. US 8242164

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  4. US 8242149

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  5. US 8242142

    Cyclohexylamines, phenylamines and uses thereof

    The Regents of the University of California · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  6. US 8242138

    Amidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  7. US 8242135

    Biphenyl derivatives

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  8. US 8242112

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  9. US 8242137

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  10. US 8242109

    Compositions and methods relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  11. US 8241862

    Perinucleolar compartment as a cancer marker

    Northwestern University · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  12. US 8242085

    Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer

    BioCryst Pharmaceuticals, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  13. US 8241863

    Identification of an evolutionarily conserved pathway mediating transrepression of inflammatory response genes by nuclear receptors

    The Regents of the University of California · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  14. US 8242074

    Modulation of the amount or function of pathogenic CD14+CD16+ monocytes

    XBIOTECH INC. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  15. US 8242093

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  16. US 8242080

    Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface

    The Regents of the University of California · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  17. US 8241638

    Induction of an immune response against dengue virus using the prime-boost approach

    United States of America as represented by the Secretary of the Air Force · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  18. US 8242076

    Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  19. US 8241249

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  20. US 8236807

    Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  21. US 8236279

    Bisaminoethanethiol-targeting ligand conjugates and compositions

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  22. US 8236797

    Bromo-phenyl substituted thiazolyl dihydropyrimidines

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  23. US 8236832

    Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  24. US 8236821

    Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

    Jenrin Discovery, LLC · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.